SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors deramiocel FDA decision for Duchenne muscular dystrophy, with a Nov. 22 target action date, dominates discussion; traders are weighing the amended upper-limb data and recent launch-related job postings as possible positive signs against the risk of another rejection. The FDAs rare-disease focus and INOVIOs approval are also cited as encouraging read-throughs, but approval expectations remain speculative and sentiment is divided.

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,809.831273 with 281,866,746.118905 in circulation. The last known price of OFFICIAL TRUMP is 1.73532194 USD and is up 9.97 over the last 24 hours. It is currently trading on 744 active market(s) with $259,407,006.57 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

A short-term bounce in the Trump-themed memecoin is drawing FOMO and pump/squeeze calls, but the conversation is predominantly bearish: traders describe it as a speculative pump-and-dump and warn of further losses, while some continue to promote accumulation or another rally.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

AAOI is drawing attention after a sharp, volatile selloff alongside AI and optical-infrastructure peers, with traders pointing to broader concerns about AI spending, valuations and possible further dilution rather than a clear company-specific trigger. Bulls are buying the dip on data-center transceiver demand and upcoming earnings, while bears remain concerned about financing, customer concentration and execution risks.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Attention centers on claims that POET optical engines were featured in Foxconns photonics ecosystem, which bullish traders view as validation of the existing collaboration and its AI-data-center opportunity; skeptics note that a demo or ecosystem mention is not proof of production orders. Traders are also weighing the reported Marvell-Lumentum deal and upcoming company updates against POETs steep decline and lack of clear commercial execution.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisks shares plunged despite strong results and a raised outlook, as traders focused on Kioxias cautious forecast and fears that NAND pricing growth and the AI-driven memory cycle may be cooling, alongside broader weakness in chip stocks. The community is split between seeing the selloff as an overreaction to solid fundamentals and viewing it as a warning that peak memory pricing and growth could be near.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovins steep selloff ahead of earnings is driving attention, with traders linking the pressure to analyst downgrades, weakness across tech and ad-related stocks, and concerns about advertising demand. Bulls argue the companys growth and cash flow make the shares undervalued, while bears worry that results or guidance could disappoint and extend the decline.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

Attention centers on ABCL635, AbCelleras investigational non-hormonal treatment for menopausal hot flashes, following positive Phase 2 results and discussion of additional safety data and longer-term durability. Traders are optimistic about the drugs potential, while others caution that the early results still need to be confirmed in further studies; recent analyst coverage has added to the interest.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

A sharp gold selloff and break of support dominate discussion, with traders pointing to repriced Fed-rate expectations and possible liquidation pressure as gold falls alongside risk assets. The community is split between calling it a failed safe haven with more downside ahead and viewing the decline as a buying opportunity or temporary washout.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus is drawing attention ahead of its Q3 results, with traders debating whether growth in oncology testing and data licensing can support the stock after its sharp, volatile run. Bulls point to expanded pharma partnerships and short-squeeze potential, while bears cite insider selling, valuation concerns, and a history of post-earnings pullbacks.

Avalanche (AVAX) is a cryptocurrency launched in 2020. Avalanche has a current supply of 470,737,946.01960015 with 444,069,146.01960015 in circulation. The last known price of Avalanche is 8.66516494 USD and is up 1.34 over the last 24 hours. It is currently trading on 1133 active market(s) with $335,296,203.46 traded over the last 24 hours. More information can be found at https://avax.network/.

Avalanche

A sharp AVAX rebound has traders focused on institutional adoption and real-world asset tokenization, especially reports of a Goldman Sachs treasury fund using an Avalanche-based network. Bulls see the activity as validation of the tokenization theme, while skeptics argue the rally may be speculative and point to AVAXs history of giving back gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Earnings Preview: Excelerate Energy (EE) Q3 Earnings Expected to Decline

Excelerate Energy (EE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

XPLR Infrastructure (XIFR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

XPLR Infrastructure (XIFR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

After Plunging 10.2% in 4 Weeks, Here's Why the Trend Might Reverse for XPLR Infrastructure (XIFR)

XPLR Infrastructure (XIFR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Bloom Energy (BE) Tops Q3 Earnings and Revenue Estimates

Bloom Energy (BE) delivered earnings and revenue surprises of +32.39% and +15.41%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

XPLR Infrastructure, LP announces date for release of third-quarter 2026 financial results

XPLR Infrastructure, LP announces date for release of third-quarter 2026 financial results XPLR Infrastructure, LP announces date for release of third-quarter 2026 financial resultsPR NewswireJUNO BEACH, Fla., Oct. 20, 2026 JUNO BEACH, Fla., Oct. 20, 2026 /PRNewswire/ -- XPLR Infrastructure, LP...

After Plunging 16% in 4 Weeks, Here's Why the Trend Might Reverse for XPLR Infrastructure (XIFR)

Fervo Energy Reaches Commercial Operation at Cape Station

FRVO's first Cape Station GeoBlock reaches commercial operation, generating 33 MW and launching revenues under its power purchase agreement.

XPLR Infrastructure (XIFR) Upgraded to Strong Buy: Here's What You Should Know

XPLR Infrastructure (XIFR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

3 Alternative Energy Stocks to Buy Amid the Escalating Iran War

BE, NNE and XIFR could benefit as the Iran conflict underscores energy-security risks and drives investment in nuclear and renewable power.

XPLR Infrastructure (XIFR) Beats Q2 Earnings and Revenue Estimates

XPLR Infrastructure (XIFR) delivered earnings and revenue surprises of +180.00% and +15.35%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

XPLR Infrastructure LP engages in the acquisition, management, and ownership of contracted clean energy portfolios with long-term cash flows. It focuses on battery storage, solar, and wind initiatives. The company was founded on March 6, 2014 and is headquartered in Juno Beach, FL.

XPLR Infrastructure LP. - Unit

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

@Spencer1133 $XIFR 

I won't. I'm invested following (after) the January 2025 strategic shift. But I admit the market re-rating is taking too long.

Since Jan 2025, the company has delivered quarter after quarter, on its new strategy.

I expected the stock to reach around $15 after 3–4 quarters and $20 by now. disapointing.

The fundamentals speak for themselves:

- $750M in FCFBG delivered in FY2025.
- Another $600–700M expected for 2026.
- Improving capital structure and debt profile (also thanks to meadle pipeline sold at 1.1 billion usd).
- Surging electricity demand and prices.

The negatives are real: restrictive US policies on renewables, borrowing rates up (market), CEPF, lawsuit, etc. But their impact is simply not comparable to the fundamentals and performance.

With a market cap of just $1.8B, a valuation similar to January/February 2025 is not justified. Market will catch up.

That said, 6–7  dead money and therefore very disapointing.

Anyone reading this can jump in.

Feed

News

Sentiment

Earnings

Fundamentals

Info

XIFR XPLR Infrastructure LP. - Unit

Fundamentals

Latest XIFR News